Tech Company Financing Transactions
AiVita Biomedical Funding Round
AiVita Biomedical, operating out of Irvine, scored $25 million from private investors.
Transaction Overview
Company Name
Announced On
1/6/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
18301 Von Karman Ave. 130
Irvine, CA 92612
USA
Irvine, CA 92612
USA
Phone
Website
Email Address
Not Recorded
Overview
Built upon expertise in stem cell growth and directed, high-purity differentiation, AiVita Biomedical has engineered safe, efficient and economical manufacturing systems to support the development and commercialization of curative and regenerative medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Keirstead
Chief Financial Officer
Scott Burell
Chief Medical Officer
Robert Dillman
Chief Operating Officer
Ed Inal
Chief Scientific Officer
Gabriel Nistor
Browse more venture capital transactions:
Prev: 1/6/2021: Terns Pharmaceuticals venture capital transaction
Next: 1/6/2021: SimpleNexus venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs